ReNeuron Group plc Change of Registered Address

RNS Number : 0194U

ReNeuron Group plc

26 June 2024

ReNeuron Group plc

("ReNeuron" or the "Company")

Change of Registered Address

ReNeuron Group plc (in administration) (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces that, as part of the Company's ongoing administration process, its registered office address has changed to Cork Gully LLP, 40 Villiers Street, London, WC2N 6NJ.

Enquiries:

Cork Gully LLP	+44 (0)20 7268 2150 or
Stephen Cork, Joint Administrator	reneuron@corkgully.com
Mark Smith, Joint Administrator

ReNeuron	www.reneuron.com/investors
Iain Ross, Executive Chairman	Via Walbrook PR


Allenby Capital Limited (Nominated Adviser and Broker)			+44 (0)20 3328 5656
James Reeve/George Payne/Dan Dearden-Williams (Corporate Finance)
Stefano Aquilino/Kelly Gardiner (Sales & Corporate Broking)

Walbrook PR (Media & Investor Relations)		+44 (0)20 7933 8780 or reneuron@walbrookpr.com
Paul McManus / Alice Woodings	+44 (0)7980 541 893 / +44 (0)7407 804 654

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CROBSGDLDXDDGSL

Reneuron (LSE:RENE)
Historical Stock Chart
From Oct 2024 to Nov 2024